ABMS Lifelong Learning CME Activity

Ethical AI Use in Medicine – A Clinical Practice Toolkit

As augmented intelligence (AI) becomes increasingly integrated into clinical practice, physicians must navigate new ethical and operational challenges. AI tools can enhance diagnostic accuracy, streamline workflows, and support personalized care, while also introducing concerns related to reliability, bias, transparency, privacy,…

Sequential Electrocardiography Changes

This case report describes a woman in her 60s with sequential type I Kounis syndrome and cholecystocardial syndrome, leading to dynamic, reversible electrocardiography changes mimicking acute coronary syndrome.

Clinician-Driven AI: Code-Free Self-Training on Public Data for Diabetic Retinopathy Referral

Importance  Democratizing artificial intelligence (AI) enables model development by clinicians with a lack of coding expertise, powerful computing resources, and large, well-labeled data sets. Objective  To determine whether resource-constrained clinicians can use self-training via automated machine learning (ML) and public data sets…

Use of Voice-Based Conversational Artificial Intelligence for Basal Insulin Prescription Management Among Patients With Type 2 Diabetes

Importance  Optimizing insulin therapy for patients with type 2 diabetes can be challenging given the need for frequent dose adjustments. Most patients receive suboptimal doses and do not achieve glycemic control. Objective  To examine whether a voice-based conversational artificial intelligence (AI) application…

Cost-effectiveness of Artificial Intelligence as a Decision-Support System Applied to the Detection and Grading of Melanoma, Dental Caries, and Diabetic Retinopathy

Objective  To assess the cost-effectiveness of artificial intelligence (AI) for supporting clinicians in detecting and grading diseases in dermatology, dentistry, and ophthalmology. Importance  AI has been referred to as a facilitator for more precise, personalized, and safer health care, and AI algorithms…

Diabetic Retinopathy Screening Among Federally Qualified Health Center Patients Using Point-of-Care AI – DRES-POCAI: A Trial Protocol

Importance  Diabetic retinopathy screening (DRS) rates have historically been low among underserved populations due to barriers in accessing traditional eye care. Although artificial intelligence (AI)–powered DRS provides a potential strategy to improve screening rates, its optimal integration into primary care workflows…